Keith Thompson is not a man to let the grass grow under his feet. Since taking the helm at the UK’s then brand-new Cell and Gene Therapy Catapult in April 2012, the former head of the Scottish National Blood Transfusion Service has made rapid progress in positioning the UK as a global leader in the development, delivery and commercialization of cell and gene therapy.
The cell and gene therapy sector is growing rapidly, Thompson says, with some 16% of all companies in this area...